Next Conference "Cancer Stem Cells: Impact on Treatment" will be organized in December 2020

The third Conference Cancer Stem Cells (CSCs): Impact on Treatment - 2020 will be devoted to the problems of primary and acquired therapy resistances associated with disease progression and poor clinical outcomes in cancer patients. It is planned that pre-clinical and clinical sessions will be included into the program of the conference. The leading basic researchers, translational researchers and clinicians will be invited to provide a number of educational lectures and to serve as chairs of the Symposium Sessions.

This Conference will highlight following CSC-related problems: 

  • signaling pathways contributing to the treatment resistance and disease progression;
  • role of CSCs in the treatment failure;
  • molecular mechanisms associated with CSC aggressiveness and increased metastatic potential;
  • CSC metabolism;
  • circadian rhythms in CSCs and metronomic chemotherapy;
  • crosstalk between CSCs and microenvironmental factors (tumor stroma, immune system);
  • biological, biochemical, pathological methods allowing CSC identification within the malignant tumors;
  • pediatric tumors and CSCs;
  • epigenetic factors in CSC formation;
  • glioblastoma stem cells;
  • development of novel biomarkers and therapeutic targets to predict and overcome therapy resistance associated with CSC activities;
  • novel therapeutic approaches to combat locally advanced, metastatic or relapsed malignant diseases;
  • chemical agents against CSCs;
  • translational oncology: how to make bridge between basic researchers and clinicians;
  • clinical trials based on pre-clinical findings

The Scientific Committee will review all submitted abstracts. Oral and poster presentations will be scheduled in the scientific program. An abstract book will be printed by the Frontiers in Oncology https://www.frontiersin.org/journals/oncology#

Druckversion | Sitemap
© Ira-Ida Skvortsova